Severe Delayed-Onset Neutropenia Induced by Ocrelizumab.
Jonathan Baird-GunningJames YunWilliam StevensonKarl NgPublished in: The Neurohospitalist (2020)
Late-onset neutropenia is a rare complication of ocrelizumab. Patients should be counseled to present for urgent evaluation if they develop fever.